#960898
Glaxo Smith Kline #00173085910

Breo® Ellipta® Fluticasone Furoate / Vilanterol 100 mcg - 25 mcg Powder 30 Doses

Name: Corticosteroid (Respiratory Tract)
Brand: Breo® Ellipta®

BREO ELLIPTA, INH 100-250MCG 30-DAY (1/EA)

Breo® Ellipta® Fluticasone Furoate / Vilanterol 100 mcg - 25 mcg Powder 30 Doses

Compare

Product Specifications

McKesson #

960898

Manufacturer #

00173085910

Brand

Breo® Ellipta®

Manufacturer

Glaxo Smith Kline

Country of Origin

Unknown

Alternate Manufacturer Number

2072874

Application

Corticosteroid (Respiratory Tract)

Buy American Act (BAA) Compliant

Container Type

Diskus

Dosage Form

Powder

Generic Drug Code

34647

Generic Drug Name

Fluticasone Furoate / Vilanterol

NDC Number

00173085910

Product Dating

McKesson Acceptable Dating: we will ship >= 90 days

Quantity

30 Doses

Strength

100 mcg - 25 mcg

Trade Agreement Act (TAA) Compliant

Type

Inhalation

UNSPSC Code

51421504

Features

BREO ELLIPTA is a combination of fluticasone furoate, an inhaled corticosteroid (ICS), and vilanterol, a long-acting beta-adrenergic agonist
BREO ELLIPTA is supplied as a disposable light grey and pale blue plastic inhaler containing 2 foil strips, each with 30 blisters
One strip contains fluticasone furoate (100 or 200 mcg per blister), and the other strip contains vilanterol (25 mcg per blister)
A blister from each strip is used to create 1 dose

Breo® Ellipta® Fluticasone Furoate / Vilanterol 100 mcg - 25 mcg Powder 30 Doses

BREO ELLIPTA, INH 100-250MCG 30-DAY (1/EA)

Product Specifications

Features

More Information

Frequently Viewed Together